The specialty chemical company is planning to raise Rs 500 crore through public issue which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by promoter and promoter group.
Specialty chemical company Tatva Chintan Pharma Chem IPO shares seem to be getting strong demand in the grey market as the premium jumped to around 60 percent over its higher end of the price band. Healthy financials, niche global play in speciality chemicals with SDAs at the centre stage, and discounted valuation compared to its peers are some of factors for strong demand, experts feel.
Shares were available at a premium of Rs 620-690 in the grey market, the IPO Central and IPO Watch data showed.
That resulted into a price of Rs 1,703-1,773 per share, a premium of 57.2-63.7 percent over higher issue price of Rs 1,083.
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.
Issue Date | 16 Jul 2021 - 20 Jul 2021 |
Issue Size | ₹500.00 Cr |
Issue Price | ₹1073-1083 |
Market Lot | 13 Shares |
Shares on Offer | |
Subscription Details | Link Intime |
Listing Date | 29 Jul 2021 |
Date | GMP | Kostak | Subject to Sauda |
---|---|---|---|
17 Jul 2020 | ₹685-690 | ₹300-350 | ₹6800-7000 |